Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Accumulated Expenses (2019 - 2025)

AVITA Medical (RCEL) has disclosed Other Accumulated Expenses for 5 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 100.53% year-over-year to $2.6 million, compared with a TTM value of $2.6 million through Dec 2025, up 100.53%, and an annual FY2025 reading of $2.6 million, up 100.53% over the prior year.
  • Other Accumulated Expenses was $2.6 million for Q4 2025 at AVITA Medical, up from $2.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.6 million in Q4 2025 and bottomed at $990000.0 in Q4 2022.
  • Average Other Accumulated Expenses over 4 years is $1.5 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses fell 17.17% in 2023, then soared 100.53% in 2025.
  • Year by year, Other Accumulated Expenses stood at $990000.0 in 2022, then grew by 27.88% to $1.3 million in 2023, then grew by 4.19% to $1.3 million in 2024, then surged by 100.53% to $2.6 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for RCEL at $2.6 million in Q4 2025, $2.4 million in Q1 2025, and $1.3 million in Q4 2024.